Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

about

Influence of Ethanol on Darunavir Hepatic Clearance and Intracellular PK/PD in HIV-Infected Monocytes, and CYP3A4-Darunavir Interactions Using Inhibition and in Silico Binding Studies.Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages.

P2860

Q40171626-372BE3F0-2BE2-40DC-B4D8-7809D25CEB86 Q47142345-7DDCA68C-0A0B-4DCC-B983-8B64C2C4D68F

P2860

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

Item

http://www.wikidata.org/entity/Q36338109

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

@ast

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

@en

type

Item

label

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

@ast

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

@en

prefLabel

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

@ast

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

@en

P1476

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

@en

P2093

Narasimha M Midde

http://www.w3.org/2001/XMLSchema#string

Santosh Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

What Will It Take to Cure HIV?

Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems

A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients

Epigenetics advancing personalized nanomedicine in cancer therapy

Development of a HIV-1 Virus Detection System Based on Nanotechnology

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Activation of latent HIV using drug-loaded nanoparticles

Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

P304

24-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26635972

http://www.w3.org/2001/XMLSchema#string

P932

4666551

http://www.w3.org/2001/XMLSchema#string

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

about

P2860

P2860

Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932